Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Genetic Technologies Sponsored ADR Representing 30 Ord Shs GENE

Technology Scientific & Technical Instruments
Genetic Technologies Limited is an Australia-based diversified molecular diagnostics company. The Company is engaged in providing genomics-based tests on health, wellness and serious disease through its geneType and EasyDNA brands. The Company offers cancer predictive testing and assessment tools to help physicians to improve health outcomes for people around the world. The Company has a... see more

Recent & Breaking News (NDAQ:GENE)

GTG Signs Precision Medicine Pilot with Australia's Largest Private Hospital Network

GlobeNewswire September 27, 2023

Aridis Pharmaceuticals, Inc., Genetic Technologies Limited, and American Resources Corporation Interviews to Air on the RedChip Money Report® on Bloomberg TV

Accesswire September 15, 2023

Breakthrough: GeneType for Pancreatic Cancer, Melanoma, and Atrial Fibrillation Cleared for Australian Release

GlobeNewswire September 12, 2023

GENE Positioned at the Forefront of Multi-cancer Clinical Utility Research - MRFF Grant names GTG as sole Industry Partner

GlobeNewswire September 11, 2023

Genetic Technologies Limited and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Money Report® on Bloomberg TV

GlobeNewswire September 1, 2023

Genetic Technologies Limited and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Money Report(R) on Bloomberg TV

Accesswire September 1, 2023

Annual Results - Momentum Building on our Commercial Plans

GlobeNewswire August 30, 2023

Genetic Technologies Limited Announces Updated Investor Presentation

GlobeNewswire August 9, 2023

Quarterly Activities Update: Encouraging Growth for geneType Commercial Test Volume

GlobeNewswire July 28, 2023

Genetic Technologies Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

GlobeNewswire July 21, 2023

GeneType featured on U.S. National TV to raise Breast Cancer Awareness

GlobeNewswire May 23, 2023

New Publication Validates geneType for Melanoma Risk Assessment

GlobeNewswire April 28, 2023

Quarterly Business Update - March 2023

GlobeNewswire April 27, 2023

Publication Validates geneType Prostate Cancer Risk Test

GlobeNewswire April 19, 2023

GeneType Multi-Risk Test now includes Melanoma, Pancreatic Cancer & Atrial Fibrillation

GlobeNewswire March 27, 2023

Back-to-back Studies Validate geneType Breast Cancer Risk Test

GlobeNewswire March 13, 2023

New Publication Highlights geneType's Ability to Detect Breast Cancer Earlier and Provide Data for Risk Stratification

GlobeNewswire February 9, 2023

Genetic Technologies Announces Closing of $5 Million Registered Direct Offering

GlobeNewswire February 7, 2023

Genetic Technologies to Launch Ground-breaking Comprehensive Risk Test for Breast & Ovarian Cancer

GlobeNewswire February 6, 2023

Genetic Technologies Announces $5 Million Registered Direct Offering

GlobeNewswire February 3, 2023